Detalhe da pesquisa
1.
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
Br J Haematol
; 204(3): 849-860, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996986
2.
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Hematol Oncol
; 42(3): e3272, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38595316
3.
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.
Cancer Sci
; 114(8): 3461-3465, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232264
4.
Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma.
Ann Hematol
; 101(5): 979-989, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35244756
5.
Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea.
Jpn J Clin Oncol
; 51(2): 218-227, 2021 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33051668
6.
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study.
Cancer Sci
; 111(10): 3770-3779, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767806
7.
Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma.
J Hepatol
; 73(2): 285-293, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32194183
8.
E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study.
Cancer Sci
; 109(3): 794-802, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363235
9.
R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.
Cancer Sci
; 109(9): 2830-2840, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29957865
10.
Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome.
Cancer Sci
; 108(12): 2445-2453, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28949050
11.
Scientific rationale for extrapolation of biosimilar data across cancer indications: case study of CT-P10.
Future Oncol
; 13(15s): 45-53, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482699
12.
Looking to the future and learning lessons from the recent past: changing stakeholder perceptions of biosimilars in cancer.
Future Oncol
; 13(15s): 17-29, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482701
13.
An introduction to biosimilar cancer therapeutics: definitions, rationale for development and regulatory requirements.
Future Oncol
; 13(15s): 5-16, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482702
14.
Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia.
Jpn J Clin Oncol
; 47(1): 54-60, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28122892
15.
A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy.
Br J Haematol
; 174(4): 571-81, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27101934
16.
Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102).
Rinsho Ketsueki
; 57(11): 2311-2318, 2016.
Artigo
em Japonês
| MEDLINE | ID: mdl-27941278
17.
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.
Clin Infect Dis
; 61(5): 719-29, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25935551
18.
Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.
Cancer Sci
; 106(2): 186-93, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25495273
19.
Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies.
Cancer Sci
; 106(7): 896-901, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25912076
20.
Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan.
Br J Haematol
; 170(5): 657-68, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953436